We have evidence of a powerful anti-viral biologic (griffithsin, also known as GRFT) that has been shown to be effective against coronaviruses and other enveloped viruses in animal models. We are forming a team to license it, biomanufacture it and deploy it globally via expression within genetically engineered rice. Our work is multidisciplinary, including genetics, plant cell culture, hardware development, and law.
We aim to provide a material means to protect all people worldwide from coronaviruses, other enveloped viruses that are inhibited by GRFT and from emerging viruses.
